These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12161133)

  • 1. Design and synthesis of conformationally restricted eight-Membered ring diketones as potential serine protease inhibitors.
    Pearson ND; Eggleston DS; Haltiwanger RC; Hibbs M; Laver AJ; Kaura AC
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2359-62. PubMed ID: 12161133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
    Xue F; Seto CT
    Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA investigations on two series of artificial peptide inhibitors of the serine protease thermitase. Synthesis of an inhibitor of predicted greater potency.
    Brandt W; Lehmann T; Willkomm C; Fittkau S; Barth A
    Int J Pept Protein Res; 1995 Jul; 46(1):73-8. PubMed ID: 7558600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Amino-α'-halomethylketones: synthetic methodologies and pharmaceutical applications as serine and cysteine protease inhibitors.
    Pace V; Castoldi L; Pregnolato M
    Mini Rev Med Chem; 2013 Jun; 13(7):988-96. PubMed ID: 22931530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Modular Synthetic Route to (+)-Pleuromutilin, (+)-12-epi-Mutilins, and Related Structures.
    Zeng M; Murphy SK; Herzon SB
    J Am Chem Soc; 2017 Nov; 139(45):16377-16388. PubMed ID: 29048164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
    Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
    J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):913-8. PubMed ID: 9871511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and inhibitory effect of pentapeptidyl chloromethyl ketones on proteinase K.
    Kore AR; Shanmugasundaram M
    Bioorg Med Chem; 2010 Dec; 18(23):8383-7. PubMed ID: 20937562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of potent and selective inhibitors of human plasma kallikrein.
    Garrett GS; McPhail SJ; Tornheim K; Correa PE; McIver JM
    Bioorg Med Chem Lett; 1999 Feb; 9(3):301-6. PubMed ID: 10091673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
    Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.
    Xu P; Xu M; Jiang L; Yang Q; Luo Z; Dauter Z; Huang M; Andreasen PA
    J Med Chem; 2015 Nov; 58(22):8868-76. PubMed ID: 26536069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.
    Glunz PW; Cheng X; Cheney DL; Weigelt CA; Wei A; Luettgen JM; Wong PC; Wexler RR; Priestley ES
    Bioorg Med Chem Lett; 2015; 25(10):2169-73. PubMed ID: 25881820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
    Cregge RJ; Durham SL; Farr RA; Gallion SL; Hare CM; Hoffman RV; Janusz MJ; Kim HO; Koehl JR; Mehdi S; Metz WA; Peet NP; Pelton JT; Schreuder HA; Sunder S; Tardif C
    J Med Chem; 1998 Jul; 41(14):2461-80. PubMed ID: 9651152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Yamashita DS; Ru Y; LoCastro SM; Oh HJ; Erhard KF; DesJarlais RL; Head MS; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; Tomaszek TA; Levy MA; Veber DF
    J Med Chem; 1998 Sep; 41(19):3563-7. PubMed ID: 9733481
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
    Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enone motif of (+)-grandifloracin is not essential for 'anti-austerity' antiproliferative activity.
    Ali Khan M; Wood PJ; Lamb-Guhren NM; Caggiano L; Kociok-Köhn G; Tosh D; Lewis SE
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2815-9. PubMed ID: 24835628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.